Hypertension affects 1 in 3 adults globally and is the leading modifiable risk factor for cardiovascular disease. Aldosterone ...

High blood pressure, also called hypertension, affects over 1.5 billion people around the world. It increases the risk of ...

Results from a clinical trial of a novel aldosterone synthase inhibitor, lorundrostat, found it significantly reduces ...

Hypertension affects one in three adults globally and is the leading modifiable risk factor for cardiovascular disease.

Expanded screening using the Vaidya & Carey algorithm significantly improved primary aldosteronism detection in patients with ...

A large number of hypertension patients may unknowingly suffer from primary aldosteronism (PA) — a common but underdiagnosed ...

The aldosterone-renin screening market is forecasted to grow from USD 574.8 million in 2025 to USD 1,109.7 million by 2035, at a CAGR of 6.8% during the forecast period. The aldosterone-renin ...

Primary hyperaldosteronism ultimately was diagnosed in 45 patients; the other 17 were presumed to have essential hypertension. After reviewing all ARR results, the authors conclude that testing ...

In her presentation at AANP 2025, Dr Haylei Lorca includes case studies of 3 patients who present with atypical psychiatric symptoms.

A novel integrated molecular imaging approach enables precise localization and quantification of heart damage, as well as ...

Primary aldosteronism is caused in the majority of cases by an aldosterone-secreting adrenal adenoma or bilateral idiopathic hyperplasia. 6, 12, 13 Less frequent etiologies of aldosterone excess ...

New Jerseyans will pick a new governor in 2025 to replace the term-limited Democrat Phil Murphy. That process starts Tuesday with the state's primary election, when voters from both parties sift ...